7,480.00
+0(+0.00%)
Currency In ZAc
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
2549
First IPO Date
March 06, 2000
| Name | Title | Pay | Year Born |
| Andrew Gideon Hall | Chief Executive Officer & Executive Director | 16.07M | 1962 |
| Basadifeela Letsoalo | Executive Director of Transformation & Human Capital and Executive Director | 7.14M | 1963 |
| Dorette Neethling | Chief Financial Officer & Executive Director | 8.76M | 1974 |
| Ashley Pearce | Managing Director of Prescription | 0 | N/A |
| Colin Sheen NDip | Managing Director of Hospital | 0 | N/A |
| Mahlatse Phalafala | Company Secretary & Head of Legal | 0 | N/A |
| Nick Ford | Managing Director of Consumer | 0 | N/A |
| Nkosinathi Mthethwa | Public Affairs Executive | 0 | N/A |
| Tobie Krige | Managing Director of Distribution | 0 | N/A |
| R. Essa | Corporate Finance Director | 0 | N/A |
Adcock Ingram Holdings Limited manufactures, markets, and distributes healthcare products in South Africa, the United States, Canada, the United Kingdom, rest of Europe, and internationally. It offers a portfolio of over the counter products, prescription medicines, and consumer products, as well as instrumentation and surgical products. The company also provides pharmaceutical products in a range of therapeutic classes, such as women's health, cannabidiol, antiretroviral, dermatology, central nervous system, respiratory, ophthalmology, generics, cardiovascular, pain, gastroenterology, energy supplements, colds and flu, personal care, feminine hygiene, digestive well-being, allergies, baby care, cough, food and nutrition supplements, vitamins, and minerals supplements. In addition, it manufactures and supplies hospital and critical care products, including intravenous solutions, renal dialysis systems, and blood collection products. The company serves private and public sectors. Adcock Ingram Holdings Limited was founded in 1890 and is headquartered in Midrand, South Africa.
